Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4K Sell
29,983
-528
-2% -$480 ﹤0.01% 3830
2026
Q1
$30.8K Sell
30,511
-19,629
-39% -$19K ﹤0.01% 3446
2025
Q4
$42.1K Buy
50,140
+18,525
+59% +$18.6K ﹤0.01% 2877
2025
Q3
$40.2K Buy
+31,615
New +$37.6K ﹤0.01% 2208
2025
Q2
Sell
-20,344
Closed -$20.1K 3041
2025
Q1
$20.1K Buy
20,344
+7,704
+61% +$8.97K ﹤0.01% 2134
2024
Q4
$16.3K Buy
+12,640
New +$14.4K ﹤0.01% 2078

Other funds holding RNXT

XTX Topco's RNXT Position: Q2 2026 in Review

XTX Topco reduced its RenovoRx (RNXT) stake by 1.7% in Q2 2026, selling an estimated $480 and leaving 29,983 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3830.

XTX Topco first reported a position in RNXT in Q4 2024 and has held it in 6 quarters since. The position peaked at $42.1K in Q4 2025. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • XTX Topco held 29,983 shares of RenovoRx worth $29.4K as of Q2 2026.
  • XTX Topco sold 528 RenovoRx shares in Q2 2026, an estimated $480.
  • RenovoRx made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3830 holding.
  • XTX Topco first reported a position in RenovoRx in Q4 2024 and has held it in 6 quarters since.
  • XTX Topco's RenovoRx position peaked at $42.1K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.